An interventional study of Artificial Intelligence in Above Knee Amputation and Amputation, sponsored by South Valley University. Recruiting at 1 site in Egypt. Open to participants aged 16 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-08-18.
Sponsored by South Valley University · Not applicable, Interventional, and Treatment
Effect of Using Artificial Intelligence on Gait Training and Balance in Above Knee Amputation Patients
South Valley University is the lead sponsor of 153 studies on the registry; 46 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Gait and Balance Training Using Artificial Intelligence
Device: Artificial Intelligence
Traditional Physical Therapy Program
using artificial intelligence in gait and balance training for above knee amputee
Medio-lateral Stability Index (MLSI)
Medio-lateral Stability Index (MLSI) represents fluctuations from the horizontal around the mediolateral axis
Time frame: Day 0, Day 90
Anterior-posterior Stability Index (APSI)
Anterior-posterior Stability Index (APSI) represents fluctuations from the horizontal around the anteroposterior axis
Time frame: Day 0, Day 90
Overall Stability Index (OSI)
Overall Stability Index (OSI) a composite of MLSI and APSI so it is sensitive to changes in both directions
Time frame: Day 0, Day 90
Plan to share: No
Started Jun 2026 (actual). Primary completion is estimated for Sep 2026, 3 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.